Search

everythinglearnresearchcommunity

for

Search:↓

The sebaceous gland plays a significant role in hair loss and thinning, and using growth stimulators, DHT inhibitors, anti-inflammatory drugs, anti-androgens, and super oxide dismuse substances can help manage it.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Hormones, especially DHT, affect hair loss and growth, and targeting specific enzymes may help treat hair loss.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Chronic hair diseases can severely affect mental health and self-confidence.

Chronic hair diseases can severely impact mental health and self-confidence.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The microstrip technique for hair transplantation is effective and discreet for patients needing fewer than 1500 grafts.

Combining robotic and specialized tools improves hair transplant results.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Androgens shorten hair growth phases, causing finer hair and more severe hair loss in men.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Hair loss in men is common, treatable, but not curable.

Higher BMI links to worse hair loss in Taiwanese men.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Some women with common hair loss may develop permanent hair loss.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.